Natco Arm Invests $8m in US’ eGenesis
Natco Pharma invests $8M in eGenesis to explore biotech breakthroughs in organ transplantation and xenotransplantation. Source and citation: ET Bureau. “Natco Arm Invests $8m in US’ eGenesis.” ET Bureau, September 5, 2024. TLDR For This Article: Natco Pharma’s Canadian subsidiary has invested $8 million in U.S.-based biotech firm eGenesis, which is pioneering xenotransplantation—developing human-compatible organs […]